Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 67

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain

Bamborough, Paul, Barnett, Heather A., Becher, Isabelle, Bird, Mark J., Chung, Chun-wa, Craggs, Peter D., Demont, Emmanuel H., Diallo, Hawa, Fallon, David J., Gordon, Laurie J., Grandi, Paola, Hobbs, Clare I., Hooper-Greenhill, Edward, Jones, Emma J., Law, Robert P., Le Gall, Armelle, Lugo, David, Michon, Anne-Marie, Mitchell, Darren J., Prinjha, Rab K., Sheppard, Robert J., Watson, Allan J. B., Watson, Robert J. · 2016 · ACS Medicinal Chemistry Letters

Abstract

The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsmedchemlett.6b00092

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 20

  1. Filippakopoulos, 2012, Histone recognition and large-scale structural analysis of the human bromodomain family, Cell, 149, 214, 10.1016/j.cell.2012.02.013 · DOI · Paper page
  2. Chung, 2011, Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains, J. Med. Chem., 54, 3827, 10.1021/jm200108t · DOI · Paper page
  3. Garnier, 2014, BET bromodomain inhibitors: a patent review, Expert Opin. Ther. Pat., 24, 185, 10.1517/13543776.2014.859244 · DOI
  4. Mirguet, 2013, Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains, J. Med. Chem., 56, 7501, 10.1021/jm401088k · DOI · Paper page
  5. Filippakopoulos, 2014, Targeting bromodomains: epigenetic readers of lysine acetylation, Nat. Rev. Drug Discovery, 13, 337, 10.1038/nrd4286 · DOI · Paper page
  6. Muller, 2014, Discovery of BET bromodomain inhibitors and their role in target validation, MedChemComm, 5, 288, 10.1039/c3md00291h · DOI
  7. Chung, 2012, Bromodomains: a new target class for small molecule drug discovery, Drug Discovery Today: Ther. Strategies, 9, e111, 10.1016/j.ddstr.2011.12.002 · DOI
  8. Carlson, 2014, The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease, J. Cell. Physiol., 229, 1571, 10.1002/jcp.24617 · DOI
  9. Ullah, 2008, Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes, Mol. Cell. Biol., 28, 6828, 10.1128/MCB.01297-08 · DOI · Paper page
  10. Poplawski, 2014, Molecular insights into recognition of N-terminal histone modifications by the BRPF1 bromodomain, J. Mol. Biol., 426, 1661, 10.1016/j.jmb.2013.12.007 · DOI
  11. Qin, 2011, Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF), J. Biol. Chem., 286, 36944, 10.1074/jbc.M111.244400 · DOI
  12. Laue, 2008, The multidomainprotein BRPF1 binds histones and is required for Hox gene expressionand segmental identity, Development, 135, 1935, 10.1242/dev.017160 · DOI
  13. Vezzoli, 2010, Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1, Nat. Struct. Mol. Biol., 17, 617, 10.1038/nsmb.1797 · DOI · Paper page
  14. Young, 2011, getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity, Drug Discovery Today, 16, 822, 10.1016/j.drudis.2011.06.001 · DOI · Paper page
  15. Demont, 2014, 1,3-Dimethyl Benzimidazolones are potent, selective inhibitors of the BRPF1 bromodomain, ACS Med. Chem. Lett., 5, 1190, 10.1021/ml5002932 · DOI
  16. Bennett, 2016, Discovery of a chemical tool inhibitor targeting the bromodomains of TRIM24 and BRPF1, J. Med. Chem., 59, 1642, 10.1021/acs.jmedchem.5b00458 · DOI
  17. Kuntz, 1999, The maximal affinity of ligands, Proc. Natl. Acad. Sci. U. S. A., 96, 9997, 10.1073/pnas.96.18.9997 · DOI · Paper page
  18. Hopkins, 2004, Ligand efficiency: a useful metric for lead selection, Drug Discovery Today, 9, 430, 10.1016/S1359-6446(04)03069-7 · DOI · Paper page
  19. Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 · DOI · Paper page
  20. Deplus, 2013, TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS, EMBO J., 32, 645, 10.1038/emboj.2012.357 · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Bamborough, P., Barnett, H. A., Becher, I., Bird, M. J., Chung, C.-W., Craggs, P. D., Demont, E. H., Diallo, H., Fallon, D. J., Gordon, L. J., Grandi, P., Hobbs, C. I., Hooper-Greenhill, E., Jones, E. J., Law, R. P., Le Gall, A., Lugo, D., Michon, A.-M., Mitchell, D. J., Prinjha, R. K., Sheppard, R. J., Watson, A. J. B., & Watson, R. J.
Affiliations
  • GlaxoSmithKline , , , Gunnels Wood Road , Stevenage, ,
  • GlaxoSmithKline , , Meyerhofstrasse 1 , ,
  • University of Strathclyde , , Thomas Graham Building, 295 Cathedral Street , ,
Venue
ACS Medicinal Chemistry Letters
Published
2016-05-09
Volume
7
Issue
6
Pages
552-557
ISSN
1948-5875
Cited by
67
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain. https://app.cochat.ai/papers/10.1021/acsmedchemlett.6b00092
The paper
Bamborough, P., Barnett, H. A., Becher, I., Bird, M. J., Chung, C.-W., Craggs, P. D., Demont, E. H., Diallo, H., Fallon, D. J., Gordon, L. J., Grandi, P., Hobbs, C. I., Hooper-Greenhill, E., Jones, E. J., Law, R. P., Le Gall, A., Lugo, D., Michon, A.-M., Mitchell, D. J., . . . Watson, R. J. (2016). GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain. ACS Medicinal Chemistry Letters. https://doi.org/10.1021/acsmedchemlett.6b00092

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.